Dengue IgGIgM and NS1 Combo Rapid Test

Dengue IgGIgM and NS1 Combo Rapid Test

Diagnostics and Laboratories

Information

VivaDiag Dengue IgGIgM and NS1 Combo Rapid Test (ANVISA-approved) detects all dengue markers in 15 minutes using colloidal gold technology. High accuracy (96-99% specificity), no equipment needed, stable at 2-30°C. Ideal for Brazil's outbreak response. Método imunocromatográfico (ouro coloidal) aprovado pela ANVISA. Resultados em 15 minutos para NS1 e anticorpos, com alta precisão (96–99%). Armazenamento estável em clima tropical (2–30°C).
VivaChek BiotechA-44VivaChek Biotech, founded in Hangzhou, China in August 2013, has evolved into a trusted and rapidly growing manufacturer of Point-of-Care Testing (POCT) products and Blood Glucose Monitoring Systems, boasting partnerships in over 120 countries globally. Our commitment to global healthcare extends to our branch offices, VivaChek Diagnostics in Sacramento, California, USA; VivaChek Life Care in Chennai, India; and VivaChek Polska in Warsaw, Poland. Today, VivaChek stands as a leading manufacturer of Blood Glucose Monitoring Systems and POCT products. This achievement is a result of meticulous management and collaboration across all departments, harnessing over 30 years of combined leadership and experience in the in vitro diagnostics (IVD) industry. We continually invest in new product development, with our R&D team members each possessing over a decade of experience in POCT product development. They have successfully optimized our existing products and are actively engaged in intelligent and efficient new product development. Our globally recognized VivaChek™ series Blood Glucose Monitoring Systems have conducted over hundreds of millions of accurate glucose tests worldwide, significantly contributing to healthier lives for individuals with diabetes. VivaChek introduced the POCT Immunofluorescence Analyzer to the international market in 2018, offering a comprehensive range of rapid tests, including cardiac markers, renal functions, tumor markers, diabetes, infection, and hormone tests. Since 2020, we've focused on developing a variety of SARS-CoV-2 tests, including IgG/IgM antibody, antigen, saliva kits, and PCR tests, to support the global fight against the pandemic. Our commitment to innovation continues with a robust pipeline, featuring the hemoglobin meter, the lipid profile (TC, TG, HDL, LDL) test system, the 4-in-1 meter for blood ketones, blood glucose, blood lactate and uric acid, an RT-PCR detection system, and numerous other groundbreaking tests. We are dedicated to delivering safe, effective and user-friendly products to customers worldwide, enhancing healthcare accessibility and outcomes for all.